Pfizer and BioNTech maintain production estimates of 4 billion COVID-19 vaccine doses in 2022

Pfizer and BioNTech expect to produce four billion doses of their COVID-19 vaccine in 2022: regardless of whether the current vaccine or a new Omicron specific vaccine is needed.